BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3062263)

  • 1. Effective and safe therapy with coenzyme Q10 for cardiomyopathy.
    Langsjoen PH; Folkers K; Lyson K; Muratsu K; Lyson T; Langsjoen P
    Klin Wochenschr; 1988 Jul; 66(13):583-90. PubMed ID: 3062263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant.
    Folkers K; Langsjoen P; Langsjoen PH
    Biochem Biophys Res Commun; 1992 Jan; 182(1):247-53. PubMed ID: 1731784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.
    Langsjoen PH; Vadhanavikit S; Folkers K
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4240-4. PubMed ID: 3858877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective treatment with coenzyme Q10 of patients with chronic myocardial disease.
    Langsjoen PH; Vadhanavikit S; Folkers K
    Drugs Exp Clin Res; 1985; 11(8):577-9. PubMed ID: 3836875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research on coenzyme Q10 in clinical medicine and in immunomodulation.
    Folkers K; Wolaniuk A
    Drugs Exp Clin Res; 1985; 11(8):539-45. PubMed ID: 3836873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10.
    Folkers K; Vadhanavikit S; Mortensen SA
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):901-4. PubMed ID: 3856239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy.
    Langsjoen PH; Folkers K; Lyson K; Muratsu K; Lyson T; Langsjoen P
    Int J Tissue React; 1990; 12(3):163-8. PubMed ID: 2276894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A six-year clinical study of therapy of cardiomyopathy with coenzyme Q10.
    Langsjoen PH; Langsjoen PH; Folkers K
    Int J Tissue React; 1990; 12(3):169-71. PubMed ID: 2276895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coenzyme Q10 in dilated cardiomyopathy.
    Manzoli U; Rossi E; Littarru GP; Frustaci A; Lippa S; Oradei A; Aureli V
    Int J Tissue React; 1990; 12(3):173-8. PubMed ID: 2276896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children.
    Soongswang J; Sangtawesin C; Durongpisitkul K; Laohaprasitiporn D; Nana A; Punlee K; Kangkagate C
    Pediatr Cardiol; 2005; 26(4):361-6. PubMed ID: 16374685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10.
    Folkers K; Wolaniuk J; Simonsen R; Morishita M; Vadhanavikit S
    Proc Natl Acad Sci U S A; 1985 Jul; 82(13):4513-6. PubMed ID: 3859873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of coenzyme Q10 in clinical cardiology: a long-term study.
    Langsjoen H; Langsjoen P; Langsjoen P; Willis R; Folkers K
    Mol Aspects Med; 1994; 15 Suppl():s165-75. PubMed ID: 7752828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials.
    Soja AM; Mortensen SA
    Mol Aspects Med; 1997; 18 Suppl():S159-68. PubMed ID: 9266518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure.
    Sander S; Coleman CI; Patel AA; Kluger J; White CM
    J Card Fail; 2006 Aug; 12(6):464-72. PubMed ID: 16911914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure.
    Mortensen SA; Vadhanavikit S; Muratsu K; Folkers K
    Int J Tissue React; 1990; 12(3):155-62. PubMed ID: 2276893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"--a multinational trial.
    Mortensen SA
    Biofactors; 2003; 18(1-4):79-89. PubMed ID: 14695923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and hemodynamic effects of coenzyme Q10 in congestive cardiomyopathy.
    Sacher HL; Sacher ML; Landau SW; Kersten R; Dooley F; Sacher A; Sacher M; Dietrick K; Ichkhan K
    Am J Ther; 1997; 4(2-3):66-72. PubMed ID: 10423594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of coenzyme Q10 in chronic heart failure, angina, and hypertension.
    Tran MT; Mitchell TM; Kennedy DT; Giles JT
    Pharmacotherapy; 2001 Jul; 21(7):797-806. PubMed ID: 11444576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coenzyme Q10 treatment in serious heart failure.
    Munkholm H; Hansen HH; Rasmussen K
    Biofactors; 1999; 9(2-4):285-9. PubMed ID: 10416042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of coenzyme Q10 in heart failure.
    Weant KA; Smith KM
    Ann Pharmacother; 2005 Sep; 39(9):1522-6. PubMed ID: 16046484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.